Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application Pharmaceutical Investing
Daré Bioscience Enters into License and Collaboration Agreement for a Product with the Potential to Receive the First FDA Approval Pharmaceutical Investing
MediciNova Announces Closing of Underwritten Public Offering of Common Stock Pharmaceutical Investing
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease Biotech Investing
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years Pharmaceutical Investing
Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M Pharmaceutical Investing
